Medline signals beyond the news: 36+ signals from 3 sources
The latest Medline signal on this page is from Sep 29, 2026 (Patents): "Medline Industries, LP's patent output is accelerating: 40 grants in the past year, 6 in the past 30 days." The busiest sources: Glassdoor (15+), LinkedIn (15+) and Patents (6).
Public (MDLN)Medical Equipment Manufacturing10,000+ employeesmedline.comLinkedIn
- Signals
- 36+
- Sources
- 3
- Last 90 days
- 21
- Latest
- Sep 29, 2026
Other signals · latest 10
Latest Medline signals by source
36+ signals for Medline across 3 sources.
Patents · Patent pace
Medline Industries, LP's patent output is accelerating: 40 grants in the past year, 6 in the past 30 days.
Over the past year Medline Industries, LP received 40 US patent grants, concentrated in software / computing and health tech / medical informatics; the recent pace (11 in 90 days) is accelerating versus its trailing baseline.
- Grants, 12 months
- 40
- Grants, 90 days
- 11
- Grants, 30 days
- 6
- Pace
- Accelerating
Patents · Patent grant
Medline Industries was granted a patent for a bottle design.
In September 2026 Medline Industries patented a bottle form for use in healthcare product packaging and handling.
- Grant date
- Sep 29, 2026
- Inventors
- Alyson Ovitt, Kimberly Washington, Mark Krukonis, Juniwati Katopo
Glassdoor · Learning development praise
Employees praise unmatched learning opportunities and exposure
Multiple reviewers mention that the company offers excellent trust, exposure, and learning opportunities, with one highlighting it as unmatched.
- Overall rating
- 3.6 of 5
- CEO approval
- 77%
- Reviews read
- 10
- Review window
- Aug 17, 2026 to Sep 3, 2026
Glassdoor · Technical debt frustration
Company growth is hindered by outdated and unscalable processes
One finance manager highlights that many old processes need updating to support company growth, suggesting a need for modernization and scalable solutions.
- Overall rating
- 3.6 of 5
- CEO approval
- 77%
- Reviews read
- 10
- Review window
- Aug 17, 2026 to Sep 3, 2026
Glassdoor · Talent retention concerns
High turnover and lack of backfill are significant issues
Multiple reviews mention extremely high turnover rates and a lack of backfilling positions, with one employee noting their top-performing sales role was eliminated.
- Overall rating
- 3.6 of 5
- CEO approval
- 77%
- Reviews read
- 10
- Review window
- Aug 17, 2026 to Sep 3, 2026
Patents · Patent grant
Medline was granted a patent for a heel protector.
In July 2026 Medline patented a protective heel-worn device intended for use in healthcare settings to help shield patients’ heels from pressure and contact.
- Patent title
- Heel protector
- Grant date
- Jul 28, 2026
- Inventors
- Reesha Talati, Drew Phalen, Staci Wood
Patents · Patent grant
Medline Industries was granted a patent for a heel protector.
In July 2026 Medline Industries patented a protective heel-support product for use in patient care settings.
- Patent title
- Heel protector
- Grant date
- Jul 28, 2026
- Inventors
- Zachary Alban, Paul Paczocha, Staci Wood, Drew Phalen
LinkedIn
Medline offers 5 ways to improve frontline team accountability and prepare them for success.
Frontline accountability is built, not demanded. How do you prepare your team for success? Here are 5 ways to start. Find out how. http://ms.spr.ly/6046v5CPj
- Likes
- 50
- Comments
- 2
- Tags
- Operations, Training
- Initiatives
- improving frontline team accountability
LinkedIn
Medline celebrates Pride Month, reinforcing commitment to diversity, inclusion, and respecting the LGBTQ+ community.
We proudly raised the Pride flag in recognition of Pride Month! Moments like these reinforce our commitment to fostering a culture where everyone feels seen, valued, and respected. At Medline, we celebrate the diversity of our employees and customers and stand with the LGBTQ+ community this month and every month...
- Likes
- 423
- Comments
- 6
- Tags
- Diversity & Inclusion, Company Culture & Policy
- Initiatives
- fostering inclusive culture
LinkedIn
Medline suggests assessing processes and centralizing uniform ordering for improved efficiencies.
As a mid-year mark across the care continuum, it’s a good time to assess processes that might drain hours. Discover how uniform ordering can be centralized to improve efficiencies. http://ms.spr.ly/6043v5ZxR
- Likes
- 38
- Comments
- 2
- Tags
- Logistics / Supply Chain, Operations, Healthcare Operations
- Initiatives
- improving operational efficiencies, centralizing uniform ordering processes
Showing 10 of 36+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Medline with the Signal API
One POST /v1/companies/enrich call with medline.com returns Medline signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "medline.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Same industry
Other signals at related companies
Questions about Medline other signals
What signals does Autobound track for Medline besides news and filings?
What do employees say about working at Medline?
Has Medline been granted patents recently?
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .